Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 2
2000 3
2001 5
2002 2
2003 2
2004 1
2005 6
2006 13
2007 10
2008 18
2009 13
2010 20
2011 21
2012 31
2013 16
2014 12
2015 5
2016 9
2017 4
2018 3
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes.
Kleinstern G, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Bertrand KA, Norman AD, Visscher DW, Couch FJ, Brandt K, Shepherd J, Wu FF, Chen YY, Cummings SR, Winham S, Kerlikowske K, Vachon CM. Kleinstern G, et al. Breast Cancer Res Treat. 2021 May;187(1):215-224. doi: 10.1007/s10549-020-06049-8. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392844 Free PMC article.
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics.
Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM. Rice MS, et al. Breast Cancer Res Treat. 2018 Jul;170(1):129-141. doi: 10.1007/s10549-018-4735-9. Epub 2018 Mar 3. Breast Cancer Res Treat. 2018. PMID: 29502324 Free PMC article.
Discovery of internalizing antibodies to basal breast cancer cells.
Zhou Y, Zou H, Yau C, Zhao L, Hall SC, Drummond DC, Farr-Jones S, Park JW, Benz CC, Marks JD. Zhou Y, et al. Protein Eng Des Sel. 2018 Jan 1;31(1):17-28. doi: 10.1093/protein/gzx063. Protein Eng Des Sel. 2018. PMID: 29301020 Free PMC article.
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Campbell JI, Yau C, Krass P, Moore D, Carey LA, Au A, Chhieng D, Giri D, Livasy C, Mies C, Rabban J, Sarode VR, Singh B, Esserman L, Chen YY. Campbell JI, et al. Breast Cancer Res Treat. 2017 Aug;165(1):181-191. doi: 10.1007/s10549-017-4303-8. Epub 2017 Jun 2. Breast Cancer Res Treat. 2017. PMID: 28577078 Free PMC article.
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.
Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM; ACRIN Trial team ISPY-1 Investigators. Bolan PJ, et al. J Magn Reson Imaging. 2017 Jul;46(1):290-302. doi: 10.1002/jmri.25560. Epub 2016 Dec 16. J Magn Reson Imaging. 2017. PMID: 27981651 Free PMC article. Clinical Trial.
178 results